Condition 1: Diseases of the circulatory system. Condition 2: complementary medicine. Condition 3: Pain and hemodynamic symptoms. Condition 4: anxiety. Angina pectoris with documented spasm Anxiety disorder, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Full consciousness Age range 18-60 years Absence of valvular heart disease Severe disease conditions Any vision, hearing, or smell disorder Absence of respiratory and allergic problems No drug addiction Absence of liver and kidney problems Not taking sedatives 4 hours before the intervention No history of any confirmed mental illness such as depression, anxiety, stress
Exclusion criteria
Exclusion criteria: Sudden occurrence of any severe changes in vital signs and the presence of dangerous cardiac dysrhythmias in patients Unwillingness to continue participating in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain related to aromatherapy. Timepoint: Before and immediately after intervention. Method of measurement: Visual Analogue Scale.;Anxiety related to aromatherapy. Timepoint: Before and immediately after intervention. Method of measurement: Depression Anxiety and Stress Scale 21 (DASS-21).;Hemodynamic parameters. Timepoint: Before and immediately after intervention. Method of measurement: Digital heart monitoring system. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ghoum University of Medical Sciences